Delivery Order SPE2DB20D7066-SPE2DB24FC2MK

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $1,251.76 for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 30, 2024 and is a firm-fixed price arrangement. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,856.46 and a period of performance through January 25, 2024. The contract was awarded on a firm fixed-price basis without any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,895.95, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a completion date of February 14, 2025 and is a Firm Fixed Price contract. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product. The firm-fixed-price contract, valued at $3,503.46, has a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,540.64, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a firm fixed price and runs until February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,459.76, is for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product, with a period of performance through August 7, 2024. The contract is not designated as a set-aside. In addition to this specific delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of SYNVISC-ONE syringes. The contract has a ceiling value of $6,025.71 and a period of performance ending on September 5, 2024. It is a firm-fixed-price contract and is not set aside for any special designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of SYNVISC-ONE SYRINGE 6ML. The contract has a ceiling value of $7,766.38 and an ultimate completion date of June 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,376.76, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a firm fixed price and a performance period through March 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a $2,804.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML. The order has a completion date of September 8, 2023. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB24FC2MK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The award, valued at $13,533.64, is a firm-fixed price contract with an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, collectively valued up to $999,999,999 and $750,000, respectively, for the provision of a wide range of medical commodities and prescription drugs to support various federal healthcare programs and facilities. This delivery order does not have a set-aside designation.

Generated 11/4/24, 10:29 AM